NasdaqCM - Nasdaq Real Time Price USD

Rein Therapeutics Inc. (RNTX)

Compare
2.0000
+0.0300
+(1.52%)
At close: January 17 at 4:00:00 PM EST
2.0000
0.00
(0.00%)
After hours: January 17 at 4:00:11 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -5.85M
Q4'23
Q1'24
Q2'24
Q3'24
-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

7.00
13.00 Average
2.0000 Current
19.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1--11
Avg. Estimate -0.480-2.24-1.88
Low Estimate -0.480-2.24-1.88
High Estimate -0.480-2.24-1.88
Year Ago EPS -------2.24

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 2122
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%0.00%0.00%0.00%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.16-1.02-0.42-0.45
EPS Actual -1.54-0.86-0.45-0.27
Difference -1.380.16-0.030.18
Surprise % -862.50%15.69%-7.14%40.00%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.480-2.24-1.88
7 Days Ago -0.440-2.13-1.78
30 Days Ago -0.440-2.13-1.78
60 Days Ago -0.440-2.13-1.78
90 Days Ago -0.440-2.13-1.78

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days ------1
Up Last 30 Days ------1
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
RNTX ------16.07%
S&P 500 9.47%11.36%13.97%13.61%

Related Tickers